You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 888 An integrative approach to optimize a synthetic EphA2/CD137 agonist: balancing potency, physiochemical properties, and pharmacokinetics to achieve robust anti-tumor activity

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
888 An integrative approach to optimize a synthetic EphA2/CD137 agonist: balancing potency, physiochemical properties, and pharmacokinetics to achieve robust anti-tumor activity
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 202121804
Dec 20215203
Jan 20223804
Feb 20224003
Mar 202211603
Apr 20224403
May 20224609
Jun 20221803
Jul 20222307
Aug 20222004
Sep 20222609
Oct 20221405
Nov 2022204
Dec 20221301
Jan 20232404
Feb 20231804
Mar 2023400
Apr 2023001
May 20231005
Jun 2023400
Jul 20231809
Aug 2023602
Sep 2023200
Oct 2023401
Nov 202328010
Dec 20232401
Jan 20241201
Feb 20241401
Mar 20241200
Apr 2024401
May 20241801
Jun 2024602
Jul 20241001
Aug 2024201
Sep 20241801
Total9080108